pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-412 |
Genomic Coordinates | chr14: 101065447 - 101065537 |
Synonyms | MIRN412, hsa-mir-412, MIR412 |
Description | Homo sapiens miR-412 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-412-3p | |||||||||||||||||||||||||||||||||||||||
Sequence | 54| ACUUCACCUGGUCCACUAGCCGU |76 | |||||||||||||||||||||||||||||||||||||||
Evidence | Not_experimental | |||||||||||||||||||||||||||||||||||||||
Experiments | DRVs in miRNA |
|
||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | OSBPL8 | ||||||||||||||||||||
Synonyms | MST120, MSTP120, ORP8, OSBP10 | ||||||||||||||||||||
Description | oxysterol binding protein like 8 | ||||||||||||||||||||
Transcript | NM_001003712 | ||||||||||||||||||||
Other Transcripts | NM_020841 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on OSBPL8 | |||||||||||||||||||||
3'UTR of OSBPL8 (miRNA target sites are highlighted) |
>OSBPL8|NM_001003712|3'UTR 1 AAGTTCTCTACCATTGAATCAGTGAACTAGAAAGATCTGATTTGGCCTGGGACCAGTGTTCAAGTTGGTTTGGTCTTTAT 81 TAAAAATCACAATATTCCGAAAACAAAAAAACCTAGGAGATAAATGTAGAGGTATTGACTTTTCGTATCTTTTATCTTCA 161 CACTGAAACAAGAGCTATCCTATTTGATTATTAAAGTGAGCTATGTGTTAAGTGCCAGGACATTTCTAGCTTTTGTGAGA 241 ATGTGTCTACATATGAGTATAATAAACCCACATGTATACACAATTGTCTCTTATGTACTCCTACCTGACAGTAGTCTTTG 321 TATTCTATAGTATGTTCTGAGATATAATGTTAACATTGTTCATAACAAAAAATGCTATCAATCTTATAAATATATGTAAT 401 CTATTTTCTTCATAAAACAGGCACAAAAGTTTTATCAGTAAGGAATTACAGATTGAGAAATGATGGAATAATAGACATAA 481 TTAATTCAATACACTACTGTTAAAATCATTTGCAAAGCACTCAGCTCAATTATCTTCTTAGAAAGAAAGAAAAAGTATGA 561 ATGGTCAAAATGAATACATCGAGAGAGATAAATGGCAAATTGCTTTTTTAAAAGTTTACATAAGTTTTTTTTAACCCCTA 641 GAATTTAATATTTGTAGATGCAGGTAAATATATATACTTACGTGTATATCAGTATAAAAACACTGGTGTGCAATTAATTG 721 GATTGATTATAATACCACCTTAAGCACTTGCTGAAAAAAGTGTGGTCAAAATTGATTGCTGTCCTTTTGTCTTATTTTTG 801 TTTTTCTTAAGTCAGCTGGTTCATAACATAGGCCAAATTCTAGAGATGTTTATAGAGCATTTGAAGTGCTGATAATTTAT 881 GTTTTTTCATTATGAAAACTTATTTTAGCTTTAGACTCCAGTGTGTTCAGTGAATAAGTAGAATATAAAAAAATATAACC 961 AGTATTTTACTTCAAAAGCCAAAAAGAGGCAATAAGAAAAGACACTTTGTGGTGGCCTTTATGTGTGCATTAAAATTGGT 1041 TTCTGTAAAACGTGTAATAAGTTGAGTATCTACGAAGAGTATCAAGTTCTGAAGTTTAATTTTTTTATTATCCTCCTCTC 1121 TTCTTAGTAACTTCTTTCTGTGGCAAAACCACAATTCTTTAAGATTCCTATTGTTCAGGCTAAGGCAAATTTTTTTGTTT 1201 GTTTCTTCAGTTTAATATTTTGATTTTGTGTTTTTACGTAAATATTTATATTCCTTGAAAGCAATTTTTGCCAAGGTAGT 1281 TCAGTTTAGGAATATGTTGTTCTAAAATATGTCTTAGAATCCTGAAAGCATAGATTTTGAAATGTTTTTTTAATGAAAAT 1361 GAAGGTCAGAGAGAATAATTGCCCTGACCACATTTGCCTTTCAGTAGGAGGAGGCTGTGAAATAGTAAAATTATAATCGT 1441 TTATGCCATGATAAATACAAGATTGGTAAATAAATACATTGATTGGTAAATTATGAGAATCAAAATGATAAAAAGAGCCT 1521 GCTTTTTTCCCTAACCAATATAGCTATCTTAAGTATCCTTAGGTTTCTGTGAAGAACCATTTCCCATGTTTTCTTGGCAA 1601 AATAATGCTGTATTCCATATGTACATGTGAAATGATGTTTTAAATTGATAAAAGCTTAAATAAGATCTACCTATACCCAG 1681 TATTTTCATGATATTAGAACAAATGGGTTTTTGGTTATATTTTATATTTGTCAATATAATTTTTGTATTCACATTCTGTT 1761 ACACTCTGCCTATTCATTGATATATGATATTCTGTAAATATTGTACAATTTGATCTTTTTTATGGTTTAAATTAGTTAAT 1841 TACATACAAATTGATTGGCTTATCACAAAAATCATTTCATCAGTAAACCTTGTTAACATTTTGTACTGGTGACCCACCTC 1921 TTAGGACTTTGGTCTTATCCACGTGTATGTTGTTTTCATTTGGTCCAAATAATATTTTATTTGTATGGGTATCTTCTAAG 2001 ACTAAATAGGTAGTTGTGTTCTTTATTTTTAAAATTTCTTTTTAGAGCAAATGTTATGGGTTCTTACCCAAAGAGTCAAA 2081 AACTATTTCTTAAGAAAGAGCAGAGTTATTCATGACTGTTCTTTATACACTAAAAGCATGCATCTAATCTAATAGTCCTC 2161 TTATTATGCTTTTAGTTGTATGAGTCTCTTTCTATGAACTGAACACAAAACTCAGGAATTGGTGGCTTAATTTTAGATCA 2241 GTGCTTGTACTAGGCTTAGTTATATGAATCTTTATAACACATAATTACTAACTTTGTAGCCATATATGTAATTGACTTTG 2321 AATGTTATTTACCTGAAATTAATCTTCCTTCACACATGGACCGTAAACGGTTCCCAGTTGTCTGAGAGCCTCATGAGGGT 2401 TTCTAGGATTTATGACCTTATGACCAGTTTTTTTCATTTACCAAGATTTTATTTTCCTACATGAAAATTTAATTGAGTAA 2481 TAATTATTCACATGTGCATTTTCTTTTTAGCTGTTAAATGTACTATGCCATCATCCACCATTTAGTAAAATGTAGCTGGC 2561 CCAGGACATGTAAAAAAAAAAAAAAAACAACAACAATAAATAGGGCATGTGAAATGTTAAGTTACAGCAATAGATATTTT 2641 ATTTGTATTTCATGTTAGTACTTTTTTGTTTTATATCACTTATAAAGGTACAGTGTACTCTTTGTCACAGCTCAGTTGGT 2721 AACCGCATTCCATTGAAAAGTTGGCCTTGTAAAATACAACTCTCATTTAATATTCATGCTTTTGTGCCTTTAAGAAAATA 2801 TTTTTTGTCATTTTTTGTGTTACAGAACTATAATGTGATTCAAGGTGTTTATAGGCTTGTCATAAAAGGGTCATTTCTGT 2881 GTGTTACTTTCTTTTTATATAGCTATAGTATATTTAAACAATAATACTATCTTTTATAGGGGTTTGTCTATTTACCTATT 2961 CTTTACTCAGACATTGATGTAGACTTGTCAGATTATTCTGAGTATTGTTAACAGTGCCTTTTCGATGGAATCACACTTTT 3041 TGGCTGTCACCTTGTGCCATATACACACAAAATTTTGTGGAAGGCAGTTTTAACTTTCTGAAGAATATCTGTCAAAATTT 3121 AAGAAAACAAATGTATAAAATTCCATTTTTTCCAGTGTTTAGCATTTCTAGTAAGCAGTGAGGTTGTTTGACATACAGTG 3201 ATGATGGCATTATTGATAAGCCATACATGAGACTGCAGATTATATTGAATCATATTAAATGTACAGAAATAAAATATTAG 3281 ATTTATATCAAATTTTCCAATTTGAACCAGTGGGGAAAATCCCACAGAAATCAGTAAGTTTACATTTCAATTTCTATCTT 3361 ATTTGACTAAGTGGAAAGAGATTCTTTAAAATGTATAACCTGCCATTATGTAATTTGGTTTCATTTTATTCTACCTGTTG 3441 TGTGAGTTTAGTATATTTAATTTACTTTTTGTTACTCTTTACATACTGTTTATTTTTGTTAGTTTTTAATTGAAGATGGA 3521 CTGTTGAAATTGTATAGGACCAGTGTCTTATTAATATGATTAATATATTTAGAAGAGCCACGTGAAACCCATGACAAAAT 3601 GAATGTGAATATTCTTTCTAAAAATTTAGAAAATGTTATCTTTTTGCATTTATTATGTAAAACTGTTTTACAGTATCAAA 3681 ATTTTTCACTTAAAGAAAAAAAATGCCATGAAACATTTGAACTGATGAGCCACAGAACTTCAGTTGAAATTTTTTTCACT 3761 TTTTAGCATGCTAAATATACATCTGAGTTTAAATGTTCTGTTTAATGGCCATTCATAAATTCAAGCACTACCACTGGTCA 3841 GTTTTGTGTGATAGAATAAAAATATGTTACCTGCAGTGTAAGTACAGCACACTGTCAAATTCTTTTCCTTAAGGTGCACA 3921 GTAAATGTACAGATAGTTATAGGCCACTGTTTTGTAATGTAGTACATTTCTAATCTATTATTCCTAACCTATTATAACTG 4001 TTTGCAGAAAGAAAAGAATTTTTCTAATAATCTGTAAAATTATGCTAACTTCTACAAGTAGGCTTCTAAATAAAATTTTT 4081 AAAAAGAGCAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | islets |
Tools used in this research | TargetScan |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in Supplenentary. RNA binding protein: AGO.
... - Kameswaran V; Bramswig NC; McKenna LB; Penn et al., 2014, Cell metabolism. |
Article |
- Kameswaran V; Bramswig NC; McKenna LB; Penn et al. - Cell metabolism, 2014
Type 2 diabetes mellitus (T2DM) is a complex disease characterized by the inability of the insulin-producing beta cells in the endocrine pancreas to overcome insulin resistance in peripheral tissues. To determine if microRNAs are involved in the pathogenesis of human T2DM, we sequenced the small RNAs of human islets from diabetic and nondiabetic organ donors. We identified a cluster of microRNAs in an imprinted locus on human chromosome 14q32 that is highly and specifically expressed in human beta cells and dramatically downregulated in islets from T2DM organ donors. The downregulation of this locus strongly correlates with hypermethylation of its promoter. Using HITS-CLIP for the essential RISC-component Argonaute, we identified disease-relevant targets of the chromosome 14q32 microRNAs, such as IAPP and TP53INP1, that cause increased beta cell apoptosis upon overexpression in human islets. Our results support a role for microRNAs and their epigenetic control by DNA methylation in the pathogenesis of T2DM.
LinkOut: [PMID: 24374217]
|
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
138 hsa-miR-412-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT005780 | ACVR1C | activin A receptor type 1C | 1 | 1 | ||||||||
MIRT062013 | YOD1 | YOD1 deubiquitinase | 2 | 2 | ||||||||
MIRT345112 | ATXN7L3 | ataxin 7 like 3 | 2 | 2 | ||||||||
MIRT383735 | EDEM3 | ER degradation enhancing alpha-mannosidase like protein 3 | 2 | 2 | ||||||||
MIRT396956 | CELF1 | CUGBP Elav-like family member 1 | 2 | 2 | ||||||||
MIRT439280 | XIAP | X-linked inhibitor of apoptosis | 1 | 1 | ||||||||
MIRT439313 | VAT1 | vesicle amine transport 1 | 1 | 1 | ||||||||
MIRT439375 | TUBA1A | tubulin alpha 1a | 1 | 1 | ||||||||
MIRT439418 | TMOD1 | tropomodulin 1 | 1 | 1 | ||||||||
MIRT439503 | SURF4 | surfeit 4 | 1 | 1 | ||||||||
MIRT439563 | SON | SON DNA binding protein | 1 | 1 | ||||||||
MIRT439598 | SLC3A2 | solute carrier family 3 member 2 | 1 | 1 | ||||||||
MIRT439670 | SETD1B | SET domain containing 1B | 1 | 1 | ||||||||
MIRT439767 | RMND5A | required for meiotic nuclear division 5 homolog A | 1 | 1 | ||||||||
MIRT439922 | PPL | periplakin | 1 | 1 | ||||||||
MIRT439947 | PLEKHA6 | pleckstrin homology domain containing A6 | 1 | 1 | ||||||||
MIRT439952 | PLCB4 | phospholipase C beta 4 | 1 | 1 | ||||||||
MIRT439961 | PKD1 | polycystin 1, transient receptor potential channel interacting | 1 | 1 | ||||||||
MIRT440005 | PEG3 | paternally expressed 3 | 1 | 1 | ||||||||
MIRT440061 | OSBPL8 | oxysterol binding protein like 8 | 1 | 1 | ||||||||
MIRT440166 | MYH14 | myosin heavy chain 14 | 1 | 1 | ||||||||
MIRT440276 | MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 | 1 | 1 | ||||||||
MIRT440437 | IPO13 | importin 13 | 1 | 1 | ||||||||
MIRT440441 | INTS3 | integrator complex subunit 3 | 1 | 1 | ||||||||
MIRT440448 | INS | insulin | 1 | 1 | ||||||||
MIRT440461 | IGF2R | insulin like growth factor 2 receptor | 1 | 1 | ||||||||
MIRT440472 | IARS | isoleucyl-tRNA synthetase | 1 | 1 | ||||||||
MIRT440530 | GUCY1A3 | guanylate cyclase 1 soluble subunit alpha | 1 | 1 | ||||||||
MIRT440542 | GOLGA2 | golgin A2 | 1 | 1 | ||||||||
MIRT440569 | GIGYF1 | GRB10 interacting GYF protein 1 | 1 | 1 | ||||||||
MIRT440608 | FTSJD2 | cap methyltransferase 1 | 1 | 1 | ||||||||
MIRT440750 | EEF1A2 | eukaryotic translation elongation factor 1 alpha 2 | 1 | 1 | ||||||||
MIRT440781 | DOT1L | DOT1 like histone lysine methyltransferase | 1 | 1 | ||||||||
MIRT440804 | DNAJA4 | DnaJ heat shock protein family (Hsp40) member A4 | 1 | 1 | ||||||||
MIRT440867 | CSDE1 | cold shock domain containing E1 | 1 | 1 | ||||||||
MIRT440890 | CPEB4 | cytoplasmic polyadenylation element binding protein 4 | 1 | 1 | ||||||||
MIRT440917 | COL1A1 | collagen type I alpha 1 chain | 1 | 1 | ||||||||
MIRT440967 | CDH22 | cadherin 22 | 1 | 1 | ||||||||
MIRT440968 | CDH2 | cadherin 2 | 1 | 1 | ||||||||
MIRT441024 | CALR | calreticulin | 1 | 1 | ||||||||
MIRT441278 | ACTB | actin beta | 1 | 1 | ||||||||
MIRT448421 | TNFAIP3 | TNF alpha induced protein 3 | 2 | 2 | ||||||||
MIRT462833 | BCL3 | B-cell CLL/lymphoma 3 | 2 | 2 | ||||||||
MIRT465062 | TSR1 | TSR1, ribosome maturation factor | 2 | 2 | ||||||||
MIRT476050 | GRSF1 | G-rich RNA sequence binding factor 1 | 2 | 2 | ||||||||
MIRT485318 | MZT1 | mitotic spindle organizing protein 1 | 2 | 4 | ||||||||
MIRT493584 | HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | 2 | 6 | ||||||||
MIRT494567 | BAK1 | BCL2 antagonist/killer 1 | 2 | 2 | ||||||||
MIRT497393 | RALY | RALY heterogeneous nuclear ribonucleoprotein | 2 | 2 | ||||||||
MIRT503250 | ZNF257 | zinc finger protein 257 | 2 | 10 | ||||||||
MIRT503656 | ZNF138 | zinc finger protein 138 | 2 | 10 | ||||||||
MIRT505882 | RNF219 | ring finger protein 219 | 2 | 2 | ||||||||
MIRT507525 | DSTN | destrin, actin depolymerizing factor | 2 | 4 | ||||||||
MIRT510663 | TMBIM6 | transmembrane BAX inhibitor motif containing 6 | 2 | 4 | ||||||||
MIRT514682 | ZNF701 | zinc finger protein 701 | 2 | 4 | ||||||||
MIRT515370 | ZNF208 | zinc finger protein 208 | 2 | 6 | ||||||||
MIRT525237 | KCNJ12 | potassium voltage-gated channel subfamily J member 12 | 2 | 2 | ||||||||
MIRT527963 | MTAP | methylthioadenosine phosphorylase | 2 | 2 | ||||||||
MIRT528482 | STAMBPL1 | STAM binding protein like 1 | 2 | 2 | ||||||||
MIRT529909 | C1orf64 | steroid receptor associated and regulated protein | 2 | 4 | ||||||||
MIRT531558 | SRD5A1 | steroid 5 alpha-reductase 1 | 2 | 2 | ||||||||
MIRT532234 | KLF2 | Kruppel like factor 2 | 2 | 4 | ||||||||
MIRT532480 | HOXA13 | homeobox A13 | 2 | 2 | ||||||||
MIRT535544 | P2RY2 | purinergic receptor P2Y2 | 2 | 2 | ||||||||
MIRT547311 | NR1D2 | nuclear receptor subfamily 1 group D member 2 | 2 | 2 | ||||||||
MIRT551795 | ZNF117 | zinc finger protein 117 | 2 | 4 | ||||||||
MIRT554939 | RAP1A | RAP1A, member of RAS oncogene family | 2 | 2 | ||||||||
MIRT558171 | EIF5A2 | eukaryotic translation initiation factor 5A2 | 2 | 2 | ||||||||
MIRT568771 | LY6K | lymphocyte antigen 6 family member K | 2 | 2 | ||||||||
MIRT570766 | ZNF99 | zinc finger protein 99 | 2 | 2 | ||||||||
MIRT572405 | MRPS14 | mitochondrial ribosomal protein S14 | 2 | 2 | ||||||||
MIRT573396 | DLC1 | DLC1 Rho GTPase activating protein | 2 | 2 | ||||||||
MIRT610403 | RXRB | retinoid X receptor beta | 2 | 2 | ||||||||
MIRT610886 | SCN8A | sodium voltage-gated channel alpha subunit 8 | 2 | 2 | ||||||||
MIRT611197 | TMEM105 | transmembrane protein 105 | 2 | 2 | ||||||||
MIRT611244 | ZNF550 | zinc finger protein 550 | 2 | 2 | ||||||||
MIRT615669 | LRIG2 | leucine rich repeats and immunoglobulin like domains 2 | 2 | 4 | ||||||||
MIRT617974 | DOCK4 | dedicator of cytokinesis 4 | 2 | 2 | ||||||||
MIRT619150 | ZNF326 | zinc finger protein 326 | 2 | 2 | ||||||||
MIRT619608 | MKKS | McKusick-Kaufman syndrome | 2 | 2 | ||||||||
MIRT621053 | DGKD | diacylglycerol kinase delta | 2 | 2 | ||||||||
MIRT623665 | HRK | harakiri, BCL2 interacting protein | 2 | 2 | ||||||||
MIRT624883 | AASDHPPT | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 2 | 2 | ||||||||
MIRT624939 | MARCH2 | membrane associated ring-CH-type finger 2 | 2 | 2 | ||||||||
MIRT634198 | TMOD2 | tropomodulin 2 | 2 | 4 | ||||||||
MIRT636727 | AGO2 | argonaute 2, RISC catalytic component | 2 | 2 | ||||||||
MIRT637741 | POLR3K | RNA polymerase III subunit K | 2 | 2 | ||||||||
MIRT638002 | ZC3H13 | zinc finger CCCH-type containing 13 | 2 | 2 | ||||||||
MIRT640395 | ZNF785 | zinc finger protein 785 | 2 | 2 | ||||||||
MIRT640505 | ANTXR1 | anthrax toxin receptor 1 | 2 | 2 | ||||||||
MIRT641293 | SLAMF1 | signaling lymphocytic activation molecule family member 1 | 2 | 2 | ||||||||
MIRT641863 | STOML1 | stomatin like 1 | 2 | 2 | ||||||||
MIRT642600 | C14orf180 | chromosome 14 open reading frame 180 | 2 | 2 | ||||||||
MIRT642895 | CASP1 | caspase 1 | 2 | 2 | ||||||||
MIRT643967 | FHL2 | four and a half LIM domains 2 | 2 | 4 | ||||||||
MIRT645237 | KCTD12 | potassium channel tetramerization domain containing 12 | 2 | 2 | ||||||||
MIRT646621 | CENPL | centromere protein L | 2 | 2 | ||||||||
MIRT648620 | CYB561A3 | cytochrome b561 family member A3 | 2 | 2 | ||||||||
MIRT648908 | ZNF551 | zinc finger protein 551 | 2 | 2 | ||||||||
MIRT649439 | HIBADH | 3-hydroxyisobutyrate dehydrogenase | 2 | 2 | ||||||||
MIRT650637 | LTF | lactotransferrin | 2 | 2 | ||||||||
MIRT650971 | STARD3NL | STARD3 N-terminal like | 2 | 2 | ||||||||
MIRT651067 | ZNF518B | zinc finger protein 518B | 2 | 4 | ||||||||
MIRT652384 | TMEM55A | phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2 | 2 | 2 | ||||||||
MIRT653958 | SEPN1 | selenoprotein N | 2 | 2 | ||||||||
MIRT656885 | KIF1C | kinesin family member 1C | 2 | 2 | ||||||||
MIRT657965 | GAPVD1 | GTPase activating protein and VPS9 domains 1 | 2 | 2 | ||||||||
MIRT658080 | FOXR2 | forkhead box R2 | 2 | 2 | ||||||||
MIRT662570 | IL2RA | interleukin 2 receptor subunit alpha | 2 | 2 | ||||||||
MIRT663089 | METTL10 | EEF1A lysine methyltransferase 2 | 2 | 2 | ||||||||
MIRT683705 | ZNF195 | zinc finger protein 195 | 2 | 2 | ||||||||
MIRT683835 | ZNF682 | zinc finger protein 682 | 2 | 2 | ||||||||
MIRT706811 | APOL4 | apolipoprotein L4 | 2 | 2 | ||||||||
MIRT707575 | DYNC2LI1 | dynein cytoplasmic 2 light intermediate chain 1 | 2 | 2 | ||||||||
MIRT708606 | ZNF260 | zinc finger protein 260 | 2 | 2 | ||||||||
MIRT708859 | TMSB4X | thymosin beta 4, X-linked | 2 | 2 | ||||||||
MIRT709861 | PDIK1L | PDLIM1 interacting kinase 1 like | 2 | 2 | ||||||||
MIRT709987 | RBM41 | RNA binding motif protein 41 | 2 | 2 | ||||||||
MIRT710098 | KPNA5 | karyopherin subunit alpha 5 | 2 | 2 | ||||||||
MIRT710211 | ENAH | ENAH, actin regulator | 2 | 2 | ||||||||
MIRT710868 | B3GALNT1 | beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) | 2 | 2 | ||||||||
MIRT710986 | SUSD5 | sushi domain containing 5 | 2 | 2 | ||||||||
MIRT711460 | RNF145 | ring finger protein 145 | 2 | 2 | ||||||||
MIRT712302 | PGM2L1 | phosphoglucomutase 2 like 1 | 2 | 2 | ||||||||
MIRT713609 | SYTL4 | synaptotagmin like 4 | 2 | 2 | ||||||||
MIRT713789 | MAK16 | MAK16 homolog | 2 | 2 | ||||||||
MIRT715480 | MYO9B | myosin IXB | 2 | 2 | ||||||||
MIRT716328 | POU5F1 | POU class 5 homeobox 1 | 2 | 2 | ||||||||
MIRT717252 | TMEM246 | transmembrane protein 246 | 2 | 2 | ||||||||
MIRT718077 | CLIC5 | chloride intracellular channel 5 | 2 | 2 | ||||||||
MIRT718463 | EED | embryonic ectoderm development | 2 | 2 | ||||||||
MIRT718645 | NKPD1 | NTPase KAP family P-loop domain containing 1 | 2 | 2 | ||||||||
MIRT718982 | PIGO | phosphatidylinositol glycan anchor biosynthesis class O | 2 | 2 | ||||||||
MIRT721078 | RPS9 | ribosomal protein S9 | 2 | 2 | ||||||||
MIRT721419 | SEC24A | SEC24 homolog A, COPII coat complex component | 2 | 2 | ||||||||
MIRT721863 | CENPJ | centromere protein J | 2 | 2 | ||||||||
MIRT722492 | PNKD | paroxysmal nonkinesigenic dyskinesia | 2 | 2 | ||||||||
MIRT723391 | CALN1 | calneuron 1 | 2 | 2 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|